Copyright
©The Author(s) 2015.
World J Stem Cells. Apr 26, 2015; 7(3): 556-567
Published online Apr 26, 2015. doi: 10.4252/wjsc.v7.i3.556
Published online Apr 26, 2015. doi: 10.4252/wjsc.v7.i3.556
Disease model | Anti-inflammatory MSC effects | Negative/neutral studies? |
Type 1 diabetes | ↑ Regulatory T cells[15-17,19] ↓ Inflammatory T cells[16,17] TH1 → TH2[16,19] ↑ Tissue repair[18-20] | None reported |
Pancreatic islet transplantation | ↑ Islet survival[22-24] ↑ Regulatory T cells[22,24] ↓ TH1 cytokines[22] ↓ T cell responsiveness[23] | None reported |
Experimental autoimmune arthritis | ↓ Inflammatory cytokines[27,29-31] ↑ Regulatory T cells[27,28,30,34] ↓ T cell responsiveness[27] ↑ IL-10[28-30] ↓ TH1/TH17 cells[28,30] ↑ TH2 cells[30,34] | No suppression[31-33] |
Graft-vs-host disease | ↓ Auto-antibodies[38] ↓ Inflammatory cytokines[39,42,44,53] ↑ Regulatory T cells[40] ↓ T cell proliferation[44] ↓ TH1 cells[49] | Prevented disease, but no effect after disease onset[43,47] No suppression[48,50,51] Reduced pathology but no effect on survival[49] |
Experimental autoimmune encephalomyelitis | ↓ T cell responsiveness[58] ↓ CNS infiltration[59-61,64,68] ↓ Auto-antibodies[59] ↓ Inflammatory cytokines[60,64,68] TH1 → TH2[61] ↓ TH17 cells[64] | None reported |
Inflammatory bowel disease | ↓ Inflammatory T cells[72,73,78] ↓ Inflammatory cytokines[72-76] ↑ Anti-inflammatory cytokines[72-75,78] ↓ Intestinal CD4+ T cell infiltration[72-74] ↑ Regulatory T cells[72-75,78] ↓ Growth factor expression[76] ↑ FasL-mediated T cell apoptosis[78] ↓ T cell responsiveness[73] | None reported |
Systemic lupus erythematosus | ↓ Anti-DNA antibodies[82-85] ↑ Regulatory T cells[82] ↓ T cell frequency[83] ↓ TH17 cells[82] ↓ Plasma cells[82] ↓ Inflammatory cytokines[85] ↑ Anti-inflammatory cytokines[85] | Worsened disease, increased auto-antibodies[87] |
Experimental autoimmune uveitis | ↓ Inflammatory cytokines[93-95] ↑ IL-10[93,94] ↑ Regulatory T cells[92-95] ↓ Inflammatory T cells[95] ↓ TH1 cells[93] ↓ TH17 cells[93,95] ↑ IL-10-producing B cells[93] | Not effective late in disease course, but effective before and shortly after disease onset[94] |
- Citation: Klinker MW, Wei CH. Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. World J Stem Cells 2015; 7(3): 556-567
- URL: https://www.wjgnet.com/1948-0210/full/v7/i3/556.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v7.i3.556